Skip to content

Techniques of providing pain relief during placement of cannula in the neck

Comparison of Superficial Cervical Plexus Block With Local Infiltration For Internal Jugular Vein Cannulation In Trauma Emergency Settings: A Prospective, Randomized Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051345
Enrollment
60
Registered
2023-04-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Superficial cervical plexus block: The superficial cervical plexus block will be administered at the time of central line insertion Control Intervention1: Local anesthetic infiltration:

Sponsors

Department of Anaesthesia and Intensive Care
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: trauma patients scheduled for awake ultrasound-guided central line placement in the internal jugular vein will be included in the study

Exclusion criteria

Exclusion criteria: patients with coagulopathy, infection at the insertion site, patients with psychiatric illness, patients with focal neurological deficits, patients with allergy to any of the drugs used in the study and patients who refuse consent

Design outcomes

Primary

MeasureTime frame
Pain during central line insertionTimepoint: At baseline

Secondary

MeasureTime frame
1. Central line insertion time (time interval from needle insertion to end of suturing) 2. Patient discomfort during the procedure as measured by 11-point verbal numeric rating discomfort scale (VNRDS) from 0 to 10 (0: None, 10: Extreme discomfort)5 3. Complications, if any Timepoint: At the time of central line insertion

Countries

India

Contacts

Public ContactNidhi Bhatia

PGIMER

nidhi.bhatia75@gmail.com9914207483

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026